Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice
- PMID: 10989246
- DOI: 10.1016/s0885-3924(00)00161-5
Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice
Erratum in
- J Pain Symptom Manage 2001 Mar;21(3):265
Abstract
A prospective survey was undertaken to determine the prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. Of 414 consecutive admissions, 33 patients were confused or too unwell to take part and 136 were pain-free. The remaining 245 reported 404 pains (range 1-5 per patient); of these patients, 218 (89%) had breakthrough pain and identified 361 pains (range 1-5 per patient). Breakthrough pain was classified as somatic (46%) visceral (30%), neuropathic (10%) or mixed etiology (16%). Thirty-eight percent of pains were severe or excruciating. The average number of daily breakthrough pain episodes was 4 [corrected] (range 1-14); 49% occurred suddenly. Most (59%) were unpredictable, and 72% lasted less than 30 minutes. Seventy-five percent of patients were dissatisfied with their pain control. Breakthrough pain is common among patients admitted to our hospice. It is frequent, short lasting, often unpredictable and not necessarily related to chronic pain making treatment difficult.
Similar articles
-
Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice.Palliat Med. 2001 May;15(3):243-6. doi: 10.1191/026921601678576220. Palliat Med. 2001. PMID: 11407195
-
Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.J Pain Symptom Manage. 2008 May;35(5):563-7. doi: 10.1016/j.jpainsymman.2007.06.012. Epub 2008 Feb 6. J Pain Symptom Manage. 2008. PMID: 18258412
-
Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain.J Pain. 2006 Aug;7(8):583-91. doi: 10.1016/j.jpain.2006.02.003. J Pain. 2006. PMID: 16885015
-
Breakthrough pain in cancer patients.Clin Oncol (R Coll Radiol). 2011 Aug;23(6):393-8. doi: 10.1016/j.clon.2010.12.002. Epub 2011 Jan 11. Clin Oncol (R Coll Radiol). 2011. PMID: 21227666 Review.
-
Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.Clin J Oncol Nurs. 2004 Oct;8(5):507-12. doi: 10.1188/04.CJON.507-512. Clin J Oncol Nurs. 2004. PMID: 15515284 Review.
Cited by
-
Informal hospice caregiver pain management concerns: a qualitative study.Palliat Med. 2013 Jul;27(7):673-82. doi: 10.1177/0269216313483660. Epub 2013 Apr 23. Palliat Med. 2013. PMID: 23612959 Free PMC article.
-
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.Cancers (Basel). 2021 Mar 2;13(5):1058. doi: 10.3390/cancers13051058. Cancers (Basel). 2021. PMID: 33801478 Free PMC article.
-
Incident pain and analgesic consumption decrease after samarium infusion: a pilot study.Support Care Cancer. 2007 Mar;15(3):339-42. doi: 10.1007/s00520-006-0131-9. Epub 2006 Sep 12. Support Care Cancer. 2007. PMID: 16967302
-
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients.Cancers (Basel). 2018 Jun 1;10(6):175. doi: 10.3390/cancers10060175. Cancers (Basel). 2018. PMID: 29865170 Free PMC article.
-
Events Leading to Hospital-Related Disenrollment of Home Hospice Patients: A Study of Primary Caregivers' Perspectives.J Palliat Med. 2017 Mar;20(3):260-265. doi: 10.1089/jpm.2015.0550. Epub 2016 Nov 28. J Palliat Med. 2017. PMID: 27893951 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical